Unsaturated fatty acid as functional food for the treatment of Diabetes mellitus type 2
DOI:
https://doi.org/10.33448/rsd-v10i9.17231Keywords:
Bioactive compounds; Functional properties; Insulin resistance; Monounsaturated fatty acids; Type 4 glucose transporter.Abstract
Several studies have been demonstrating to a relationship between unsaturated fatty acids, improvement of pancreatic function and insulin secretion. In this context, this review presents the most recent findings on the pathophysiology of type 2 diabetes mellitus, the action mechanism of unsaturated fatty acids on pancreatic function, and clinical studies in diabetic patients. We evaluated here articles from MedLine/PubMed and the Science direct database, published between 2014 and 2020. Of the 637 results, 13 were selected. From their analysis, we could observe that mono and polyunsaturated fatty acids can improve glycemic control as well as reduce cardiovascular risk. The most recurrent antidiabetic action regarding monounsaturated fatty acids is the ability to preserve insulin signaling, whereas polyunsaturated fatty acids action consists in the increasing expression of the type 4 glucose transporter. However, a complete understanding of the relationship between fatty acids, insulin and inflammation should be considered in future investigations.
References
American Diabetes Association, A. D. (2020). Standards of Medical Care in Diabetes—2020 Abridged for Primary Care Providers. Clinical Diabetes, 38(1), 10–38. https://doi.org/10.2337/cd20-as01
Baynes, H. W., Mideksa, S., & Ambachew, S. (2018). The role of polyunsaturated fatty acids (n-3 PUFAs) on the pancreatic β-cells and insulin action. Adipocyte, 7(2), 81–87. https://doi.org/10.1080/21623945.2018.1443662
Berlanga-Acosta, J., Mendoza-Marí, Y., Rodríguez-Rodríguez, N., García del Barco Herrera, D., García-Ojalvo, A., Fernández-Mayola, M., Guillén-Nieto, G., & Valdés-Sosa, P. A. (2020). Burn injury insulin resistance and central nervous system complications: A review. Burns Open, 4(2), 41–52. https://doi.org/10.1016/j.burnso.2020.02.001
Cagen, L. M., Deng, X., Wilcox, H. G., Park, E. A., Raghow, R., & Elam, M. B. (2005). Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements. Biochemical Journal, 385(Pt 1), 207–216. https://doi.org/10.1042/BJ20040162
Chen, L., Gnanaraj, C., Arulselvan, P., El-Seedi, H., & Teng, H. (2019). A review on advanced microencapsulation technology to enhance bioavailability of phenolic compounds: Based on its activity in the treatment of Type 2 Diabetes. Trends in Food Science & Technology, 85, 149–162. https://doi.org/10.1016/j.tifs.2018.11.026
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2011). The worldwide epidemiology of type 2 diabetes mellitus—Present and future perspectives. Nature Reviews. Endocrinology, 8(4), 228–236. https://doi.org/10.1038/nrendo.2011.183
Erkkilä, A. T., Lichtenstein, A. H., Mozaffarian, D., & Herrington, D. M. (2004). Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. The American Journal of Clinical Nutrition, 80(3), 626–632. https://doi.org/10.1093/ajcn/80.3.626
Fayh, A. P. T., Borges, K., Cunha, G. S., Krause, M., Rocha, R., de Bittencourt, P. I. H., Moreira, J. C. F., Friedman, R., da Silva Rossato, J., Fernandes, J. R., & Reischak-Oliveira, A. (2018). Effects of n-3 fatty acids and exercise on oxidative stress parameters in type 2 diabetic: A randomized clinical trial. Journal of the International Society of Sports Nutrition, 15(1), 18. https://doi.org/10.1186/s12970-018-0222-2
Fox, C. S., Golden, S. H., Anderson, C., Bray, G. A., Burke, L. E., de Boer, I. H., Deedwania, P., Eckel, R. H., Ershow, A. G., Fradkin, J., Inzucchi, S. E., Kosiborod, M., Nelson, R. G., Patel, M. J., Pignone, M., Quinn, L., Schauer, P. R., Selvin, E., & Vafiadis, D. K. (2015). Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care, 38(9), 1777–1803. https://doi.org/10.2337/dci15-0012
Fuller, N. R., Sainsbury, A., Caterson, I. D., Denyer, G., Fong, M., Gerofi, J., Leung, C., Lau, N. S., Williams, K. H., Januszewski, A. S., Jenkins, A. J., & Markovic, T. P. (2018). Effect of a high-egg diet on cardiometabolic risk factors in people with type 2 diabetes: The Diabetes and Egg (DIABEGG) Study—randomized weight-loss and follow-up phase. The American Journal of Clinical Nutrition, 107(6), 921–931. https://doi.org/10.1093/ajcn/nqy048
Huang, S., & Czech, M. P. (2007). The GLUT4 glucose transporter. Cell Metabolism, 5(4), 237–252. https://doi.org/10.1016/j.cmet.2007.03.006
Jaganathan, R., Ravindran, R., & Dhanasekaran, S. (2018). Emerging Role of Adipocytokines in Type 2 Diabetes as Mediators of Insulin Resistance and Cardiovascular Disease. Canadian Journal of Diabetes, 42(4), 446-456.e1. https://doi.org/10.1016/j.jcjd.2017.10.040
Kaur, N., Chugh, V., & Gupta, A. K. (2014). Essential fatty acids as functional components of foods- a review. Journal of Food Science and Technology, 51(10), 2289–2303. https://doi.org/10.1007/s13197-012-0677-0
Keapai, W., Apichai, S., Amornlerdpison, D., & Lailerd, N. (2016). Evaluation of fish oil-rich in MUFAs for anti-diabetic and anti-inflammation potential in experimental type 2 diabetic rats. The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology, 20(6), 581–593. https://doi.org/10.4196/kjpp.2016.20.6.581
Lenighan, Y. M., McNulty, B. A., & Roche, H. M. (2019). Dietary fat composition: Replacement of saturated fatty acids with PUFA as a public health strategy, with an emphasis on α-linolenic acid. Proceedings of the Nutrition Society, 78(02), 234–245. https://doi.org/10.1017/S0029665118002793
Liu, R., Chen, L., Wang, Y., Zhang, G., Cheng, Y., Feng, Z., Bai, X., & Liu, J. (2020). High ratio of ω-3/ω-6 polyunsaturated fatty acids targets mTORC1 to prevent high-fat diet-induced metabolic syndrome and mitochondrial dysfunction in mice. The Journal of Nutritional Biochemistry, 79, 108330. https://doi.org/10.1016/j.jnutbio.2019.108330
Look AHEAD Research Group, Wing, R. R., Bolin, P., Brancati, F. L., Bray, G. A., Clark, J. M., Coday, M., Crow, R. S., Curtis, J. M., Egan, C. M., Espeland, M. A., Evans, M., Foreyt, J. P., Ghazarian, S., Gregg, E. W., Harrison, B., Hazuda, H. P., Hill, J. O., Horton, E. S., … Yanovski, S. Z. (2013). Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. The New England Journal of Medicine, 369(2), 145–154. https://doi.org/10.1056/NEJMoa1212914
Mirmiran, P., Esfandyari, S., Moghadam, S. K., Bahadoran, Z., & Azizi, F. (2018). Fatty acid quality and quantity of diet and risk of type 2 diabetes in adults: Tehran Lipid and Glucose Study. Journal of Diabetes and Its Complications, 32(7), 655–659. https://doi.org/10.1016/j.jdiacomp.2018.05.003
Palomer, X., Pizarro-Delgado, J., Barroso, E., & Vázquez-Carrera, M. (2018). Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus. Trends in Endocrinology and Metabolism: TEM, 29(3), 178–190. https://doi.org/10.1016/j.tem.2017.11.009
Paquet, C., Propsting, S. L., & Daniel, M. (2014). Total n-3 fatty acid and SFA intakes in relation to insulin resistance in a Canadian First Nation at risk for the development of type 2 diabetes. Public Health Nutrition, 17(6), 1337–1341. https://doi.org/10.1017/S1368980013000542
Rabe, K., Lehrke, M., Parhofer, K. G., & Broedl, U. C. (2008). Adipokines and insulin resistance. Molecular Medicine (Cambridge, Mass.), 14(11–12), 741–751. https://doi.org/10.2119/2008-00058.
Rosca, M. G., Vazquez, E. J., Chen, Q., Kerner, J., Kern, T. S., & Hoppel, C. L. (2012). Oxidation of Fatty Acids Is the Source of Increased Mitochondrial Reactive Oxygen Species Production in Kidney Cortical Tubules in Early Diabetes. Diabetes, 61(8), 2074–2083. https://doi.org/10.2337/db11-1437
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., Shaw, J. E., Bright, D., Williams, R., & IDF Diabetes Atlas Committee. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice, 157, 107843. https://doi.org/10.1016/j.diabres.2019.107843
Salas-Salvadó, J., Bulló, M., Estruch, R., Ros, E., Covas, M.-I., Ibarrola-Jurado, N., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Romaguera, D., Lapetra, J., Lamuela-Raventós, R. M., Serra-Majem, L., Pintó, X., Basora, J., Muñoz, M. A., Sorlí, J. V., & Martínez-González, M. A. (2014). Prevention of diabetes with Mediterranean diets: A subgroup analysis of a randomized trial. Annals of Internal Medicine, 160(1), 1–10. https://doi.org/10.7326/M13-1725
Schwab, U., Lauritzen, L., Tholstrup, T., Haldorsson, T. I., Riserus, U., Uusitupa, M., & Becker, W. (2014). Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: A systematic review. Food & Nutrition Research, 58. https://doi.org/10.3402/fnr.v58.25145
Santos, L. R. B., & Fleming, I. (2020). Role of cytochrome P450-derived, polyunsaturated fatty acid mediators in diabetes and the metabolic syndrome. Prostaglandins & Other Lipid Mediators, 148, 106407. https://doi.org/10.1016/j.prostaglandins.2019.106407
Shah, M. S., & Brownlee, M. (2016). Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes. Circulation research, 118(11), 1808–1829. https://doi.org/10.1161/CIRCRESAHA.116.306923
Tan, E., Khoo, J., Gani, L. U., Malakar, R. D., Tay, T. L., Tirukonda, P. S., Kam, J. W., Tin, A. S., & Tang, T. Y. (2019). Effect of multidisciplinary intensive targeted care in improving diabetes mellitus outcomes: A randomized controlled pilot study – the Integrated Diabetes Education, Awareness and Lifestyle modification in Singapore (IDEALS) Program. Trials, 20(1), 549. https://doi.org/10.1186/s13063-019-3601-3
Uusitupa, M., Hermansen, K., Savolainen, M. J., Schwab, U., Kolehmainen, M., Brader, L., Mortensen, L. S., Cloetens, L., Johansson-Persson, A., Onning, G., Landin-Olsson, M., Herzig, K.-H., Hukkanen, J., Rosqvist, F., Iggman, D., Paananen, J., Pulkki, K. J., Siloaho, M., Dragsted, L., … Akesson, B. (2013). Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome—A randomized study (SYSDIET). Journal of Internal Medicine, 274(1), 52–66. https://doi.org/10.1111/joim.12044
Wanders, A. J., Alssema, M., de Koning, E. J. P., le Cessie, S., de Vries, J. H., Zock, P. L., Rosendaal, F. R., Heijer, M. den, & de Mutsert, R. (2017). Fatty acid intake and its dietary sources in relation with markers of type 2 diabetes risk: The NEO study. European Journal of Clinical Nutrition, 71(2), 245–251. https://doi.org/10.1038/ejcn.2016.204
Wang, J., He, Y., Yu, D., Jin, L., Gong, X., & Zhang, B. (2020). Perilla oil regulates intestinal microbiota and alleviates insulin resistance through the PI3K/AKT signaling pathway in type-2 diabetic KKAy mice. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 135, 110965. https://doi.org/10.1016/j.fct.2019.110965
World Health Assembly. (2013). Follow-up to the political declaration of the high-level meeting of the general assembly on the prevention and control of non-communicable diseases. Geneva: WHA. Recuperado em: 20 jul. 2021, de
https://apps.who.int/iris/bitstream/handle/10665/150161/A66_R10-en.pdf?sequence=1&isAllowed=y.
World Health Organization. (2018). Noncommunicable diseases: Country profiles 2018. World Health Organization. Recuperado 30 de junho de 2021, de https://www.who.int/publications-detail-redirect/ncd-country-profiles-2018
World Health Organization. (2020). WHO Integrated chronic disease prevention and control. WHO - World Health Organization; World Health Organization. https://www.who.int/chp/about/integrated_cd/en/
Zhang, Z., Liu, H., & Liu, J. (2019). Akt activation: A potential strategy to ameliorate insulin resistance. Diabetes Research and Clinical Practice, 156, 107092. https://doi.org/10.1016/j.diabres.2017.10.004
Zierath, J. R. (2019). Major Advances and Discoveries in Diabetes—2019 in Review. Current Diabetes Reports, 19(11). https://doi.org/10.1007/s11892-019-1255-x
Zong, G., Liu, G., Willett, W. C., Wanders, A. J., Alssema, M., Zock, P. L., Hu, F. B., & Sun, Q. (2019). Associations Between Linoleic Acid Intake and Incident Type 2 Diabetes Among U.S. Men and Women. Diabetes Care, 42(8), 1406–1413. https://doi.org/10.2337/dc19-0412
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Naiane Silva Cardoso; Julia Rosental de Souza Cruz; Ramon Alves de Oliveira Paula; Stella Maris da Silveira Duarte; Maria Rita Rodrigues; Fernanda Borges de Araújo Paula
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
